According to a new study, adults with T2D who were hospitalized with COVID-19 in northern Italy had a lower mortality rate when treated with sitagliptin.

From daily aspirin to RGN-CoV2 to zinc, the president of the United States has been treated for COVID-19 with a wide range of both authorized and unproven therapies.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

Over half of antibiotic courses in a new study exceeded guideline-recommended minimum effective durations, translating to >54 million potentially excessive days.

In COPD patients, a new study found no association between lung function decline and individual CVD outcomes, but disease exacerbations and dyspnea were implicated.

Sample: What percent of patients with rare diseases reported that the COVID-19 pandemic has had negative effects on their immediate and long-term health and well-being?

Global confirmed cases of COVID-19 have surpassed 35 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.

Behçet disease has been found to co-occur with a variety of other conditions. Click through 8 concise reviews of the evidence in this slide show.

The FDA called for more detailed information on risks associated with benzodiazepine use based on review of adverse event reports dating from 1968.

The FDA has granted dapagliflozin (Farxiga) breakthrough therapy designation for patients with chronic kidney disease.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

Women who received the HPV vaccine before age 17 reduced their risk of cervical cancer by 88% compared to unvaccinated women, new study found.

How many cases of COVID-19 have been confirmed in the US? How many people have been tested? Get your daily COVID-19 update here.

In episode 3 of Primary Viewpoints, Brigham and Women's hypertension expert Naomi Deirdre Fisher, MD, discusses the challenges of hypertension management in primary care.

Mepolizumab (Nucala) received a new indication for the treatment of hypereosinophilic syndrome in patients aged ≥12 years.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

The decision to prescribe a statin to prevent ASCVD may require considering factors in addition to global CVD risk. A short case illustrates use of the CAC score.

The possibility of a flu season wrapped in a global pandemic may have health care professionals especially worried this year.

Global COVID-19 mortalities have passed 1 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.

How current are you on CAC and its place in CVD risk assessment? This short quiz will reveal your score.